期刊
AGING-US
卷 9, 期 5, 页码 1440-1452出版社
IMPACT JOURNALS LLC
DOI: 10.18632/aging.101247
关键词
Friedreich's ataxia; induced pluripotent stem cells; cardiomyopathy; modelling
资金
- Friedrich Ataxia Research Alliance (USA, Ireland and Australasia)
- National Health and Medical Research Council (NHMRC)
- NHMRC-CSL
- NHMRC
- Australian Research Council (ARC)
- Cranbourne Fellowship
- ARC special Initiative Stem Cells Australia grant
- National Stem Cell Foundation of Australia grant
We sought to identify the impacts of Friedreich's ataxia (FRDA) on cardiomyocytes. FRDA is an autosomal recessive degenerative condition with neuronal and non-neuronal manifestations, the latter including progressive cardiomyopathy of the left ventricle, the leading cause of death in FRDA. Little is known about the cellular pathogenesis of FRDA in cardiomyocytes. Induced pluripotent stem cells (iPSCs) were derived from three FRDA individuals with characterized GAA repeats. The cells were differentiated into cardiomyocytes to assess phenotypes. FRDA iPSC- cardiomyocytes retained low levels of FRATAXIN (FXN) mRNA and protein. Electrophysiology revealed an increased variation of FRDA-cardiomyocyte beating rates which was prevented by addition of nifedipine, suggestive of a calcium handling deficiency. Finally, calcium imaging was performed and we identified small amplitude, diastolic and systolic calcium transients confirming a deficiency in calcium handling. We defined a robust FRDA cardiac-specific electrophysiological profile in patient-derived iPSCs which could be used for high throughput compound screening. This cell-specific signature will contribute to the identification and screening of novel treatments for this life-threatening disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据